November 15, 2010
The Albert Einstein College of Medicine's Biomarker Analytical Resource Center (BARC) has selected HighRes Biosolutions to automate their clinical sample testing. The BARC conducts a diverse array of immunoassay detection methodologies such as RIA, ELISA and LC/MS. The implementation of a HighRes NanoCell robotic platform will allow the group to rapidly perform these assays, and [...]
BioSurplus Taps Jackie Townsend as CMO
November 15, 2010
SAN DIEGO - BioSurplus, Inc. today announced the appointment of Jackie Townsend Konstanturos as Chief Marketing Officer. Townsend will oversee all sales and marketing activities, and focus on the company's plans to significantly expand its business and service offerings. Townsend has over 25-years of experience in marketing and positioning companies to take leadership roles in [...]
Sigma-Aldrich Corporation Announces Death of Chairman and CEO; Election of New CEO and Chairman
November 14, 2010
Conference Call Scheduled for 10:00a.m. (Central Time) on November 15, 2010 ST. LOUIS - It is with great sadness that Sigma-Aldrich Corporation (Nasdaq: SIAL) announces that Dr. Jai P. Nagarkatti, its Chairman, President and CEO, died suddenly and unexpectedly of an apparent heart attack Saturday, November 13, 2010 in St. Louis, Missouri. He was 63 [...]
November 12, 2010
OMAHA, Neb. - Transgenomic, Inc. (OTC/BB: TBIO) today announced that it has been awarded a research and development grant totaling $1,070,453.32 from the U.S. government under HR: 3590 – Patient Protection and Affordable Care Act (the “Act”) in immediately available funds. This is among the largest awards for any one company under the Act. Four [...]
Sage-N Research Optimizes Data Generation for the Sanford-Burnham Medical Research Institute
November 12, 2010
MILPITAS, Calif. - Sage-N Research Inc. (Sage-N), the world leader in computational proteomics, today announced that The Sanford-Burnham Medical Research Institute (SBMRI), a private, non-profit based research institute dedicated to finding cures for human disease, has implemented the Sage-N SORCERER Enterprise proteomics platform. The company will use the system to enhance the speed of data [...]
November 12, 2010
Newly implemented electronic laboratory notebook enables faster access to data and real-time data integrity from ongoing quality control throughout the bioanalytical workflow. Lincoln, NE - Celerion, the premier provider of innovative early stage drug development solutions, announces implementation of the electronic laboratory notebook in our global bioanalytical network. Celerion designed and implemented Labnotes, a commercially [...]
Agilent Technologies Reports Fourth Quarter 2010 Results
November 12, 2010
SANTA CLARA, Calif. - Agilent Technologies Inc. (NYSE: A) today reported revenues of $1.58 billion for the fourth fiscal quarter ended Oct. 31, 2010, 35 percent above one year ago, or 26 percent excluding the effects of the Varian acquisition and recent divestitures(2). Fourth-quarter GAAP net income was $232 million, or $0.66 per diluted share. [...]
November 12, 2010
Kegonsa Capital Partners portfolio company Semba Biosciences, Inc., and Orochem Technologies, Inc. have entered into an agreement to develop novel equipment for commercial manufacturing of pharmaceuticals. When applied to large-scale manufacturing, the equipment will perform an automated purification process that is up to twenty times more productive than current methods. This improvement will reduce health [...]
November 12, 2010
CENTER VALLEY, Pa. - Researchers have long wanted to use intact living animals as subjects for basic research, preclinical drug development, disease model studies and longitudinal studies. Olympus, a world leader in endoscopic, surgical and microscope imaging, now offers FluoView® FV1000 and FV1000-MPE microscope users three ultra-slim microscope objectives designed for minimally invasive, high-resolution in [...]
Meridian Life Science, Inc.® Expands R&D and Contract Manufacturing Facilities in Memphis
November 12, 2010
Meridian Life Science, Inc. (MLS) is investing $2.5M into facilities, equipment and infrastructure to support R&D and contract manufacturing activities. Increasing demand for contract R&D and biological reagent manufacturing has resulted in a comprehensive facilities plan that will allow MLS to meet customer needs and position the organization for further growth. This facility expansion which [...]
